Understanding DLGAP1: A Potential Drug Target and Biomarker (G9229)

Target Name: DLGAP1

NCBI ID: G9229

DLGAP1

Understanding DLGAP1: A Potential Drug Target and Biomarker

DLGAP1 (Serine/Arginine Repeated Matrix Protein 3-Like) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, kidneys, and intestines. It is characterized by the presence of a repeated matrix of serine and arginine residues, as well as a number of other conserved amino acid residues.

DLGAP1 has been identified as a potential drug target due to its involvement in a number of cellular processes that are important for tissue repair and regeneration. In addition, its expression has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of DLGAP1 is its role in the regulation of cell growth and differentiation. It is a transcription factor that has been shown to play a role in the development and maintenance of neural stem cells, and has been shown to promote the growth and differentiation of a variety of cell types.

In addition to its role in cell growth and differentiation, DLGAP1 is also involved in the regulation of cell survival and stress resistance. It has been shown to play a role in the regulation of cell apoptosis, and has been implicated in the development of a variety of diseases, including neurodegenerative disorders and cancer.

Another function of DLGAP1 is its role in the regulation of immune responses and inflammation. It has been shown to play a role in the regulation of T cell development and function, and has been implicated in the development of a variety of autoimmune disorders.

In addition to its involvement in cellular processes, DLGAP1 is also involved in the regulation of protein homeostasis. It has been shown to play a role in the regulation of protein synthesis and degradation, and has been implicated in the development of a variety of diseases, including cancer.

As a potential drug target, DLGAP1 is of interest because of its involvement in a number of important cellular processes that are important for human health and disease. Its role in cell growth and differentiation, as well as its involvement in the regulation of cell survival and stress resistance, make it a promising target for therapeutic intervention.

In addition to its potential therapeutic applications, DLGAP1 is also of interest as a biomarker for a variety of diseases. Its expression has been implicated in the development of a number of diseases, including cancer, neurodegenerative disorders, and autoimmune disorders. As such, it may be a useful diagnostic tool or target for the development of new therapies.

Overall, DLGAP1 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential therapeutic and diagnostic applications.

Protein Name: DLG Associated Protein 1

Functions: Part of the postsynaptic scaffold in neuronal cells

The "DLGAP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DLGAP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets